INFLUENCE OF EVEROLIMUS AND PEMETREXED ON THYMIDYLATE SYNTHASE EXPRESSION AS WELL AS ON PROLIFERATION AND SURVIVAL OF NON-SMALL CELL LUNG CANCER CELLS

被引：0
|
作者：
Markova, B. [1 ]
Haehnel, P. S. [2 ]
Herbertz, S. [3 ]
Schuler, M. [4 ]
Breitenbuecher, F. [1 ]
机构：
[1] Univ Klinikum Essen, Westdeutsch Tumorzentrum, Innere Klin tumorforsch, Essen, Germany
[2] Johannes Gutenberg Univ Mainz, Dept Med 3, Mainz, Germany
[3] Novartis Pharma GmbH, Business Unit Oncol, Pulheim, Germany
[4] Univ Essex, Innere Klin & Poliklin Tumorforsch, Essen, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S56 / S57
页数：2
相关论文
共 50 条
  • [1] Efficacy of Pemetrexed in Relapsed Non-Small Cell Lung Cancer and Thymidylate Synthase Expression
    Park, Choel-Kyu
    Kim, Kyu-Sik
    Oh, In -Jae
    Tseden-Ish, Manaljav
    Choi, Yoo-Duk
    Kwon, Yong-Soo
    Kim, Yoo-Il
    Lim, Sung-Chul
    Kim, Young-Chul
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 67 (03) : 191 - 198
  • [2] Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer
    Takezawa, K.
    Okamoto, I.
    Okamoto, W.
    Takeda, M.
    Sakai, K.
    Tsukioka, S.
    Kuwata, K.
    Yamaguchi, H.
    Nishio, K.
    Nakagawa, K.
    BRITISH JOURNAL OF CANCER, 2011, 104 (10) : 1594 - 1601
  • [3] Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer
    K Takezawa
    I Okamoto
    W Okamoto
    M Takeda
    K Sakai
    S Tsukioka
    K Kuwata
    H Yamaguchi
    K Nishio
    K Nakagawa
    British Journal of Cancer, 2011, 104 : 1594 - 1601
  • [4] Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer
    Cristina Chamizo
    Sandra Zazo
    Manuel Dómine
    Ion Cristóbal
    Jesús García-Foncillas
    Federico Rojo
    Juan Madoz-Gúrpide
    BMC Pulmonary Medicine, 15
  • [5] Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer
    Chamizo, Cristina
    Zazo, Sandra
    Domine, Manuel
    Cristobal, Ion
    Garcia-Foncillas, Jesus
    Rojo, Federico
    Madoz-Gurpide, Juan
    BMC PULMONARY MEDICINE, 2015, 15
  • [6] Expression of thymidylate synthase in human non-small cell lung cancer
    Otake, Y
    Tanaka, F
    Yanagihara, K
    Hitomi, S
    Okabe, H
    Fukushima, M
    Wada, H
    JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (11): : 1248 - 1253
  • [7] Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer
    Kawabata, Shigeru
    Chiang, Chun-Te
    Tsurutani, Junji
    Shiga, Hideaki
    Arwood, Matthew L.
    Komiya, Takefumi
    Gills, Joell J.
    Memmott, Regan M.
    Dennis, Phillip A.
    ONCOTARGET, 2014, 5 (04) : 1062 - 1070
  • [8] Pemetrexed for Previously Treated Patients with Non-Small Cell Lung Cancer and Differences in Efficacy according to Thymidylate Synthase Expression
    Igawa, Satoshi
    Ryuge, Shinichiro
    Wada, Mayuko
    Otani, Sakiko
    Maki, Sachiyo
    Takakura, Akira
    Katono, Ken
    Sasaki, Jiichiro
    Sato, Yuichi
    Masuda, Noriyuki
    CHEMOTHERAPY, 2012, 58 (04) : 313 - 320
  • [9] Thymidylate synthase (TS) RNA expression in non-small cell lung cancer (NSCLC): implications for personalizing pemetrexed therapy
    Gandara, David R.
    Mack, Philip C.
    Omori, Akiko
    Grimminger, Peter
    Lara, Primo N.
    Joshi, Mary-Beth M.
    Harpole, David H.
    Danenberg, Kathleen D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S400 - S400
  • [10] Predictive Significance of Thymidylate Synthase Expression in Non-small Cell Lung Cancer
    Kulda, Vlastimil
    Hrda, Kristyna
    Houdek, Zbynek
    Dobra, Jana Kolaja
    Vrzakova, Radana
    Svaton, Martin
    Safranek, Jarmil
    Dolezal, Jan
    Babuska, Vaclav
    Pesek, Milos
    Topolcan, Ondrej
    Pesta, Martin
    ANTICANCER RESEARCH, 2017, 37 (12) : 6953 - 6958
12345